{"product_id":"telarfetenofovir-alafenamide","title":"Telarfe (Tenofovir alafenamide)","description":"• Product name:\u003cstrong\u003e Telarfe\u003c\/strong\u003e\r\n\r\nCommon name: Tenofovir alafenamide.\r\n\r\n\u003cstrong\u003eIndications\u003c\/strong\u003e\r\n\u003cp style=\"padding-left: 40px;\"\u003eTrafene is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor used for treatment\u003c\/p\u003e\r\n\u003cp style=\"padding-left: 40px;\"\u003eAdult patients with chronic hepatitis B virus (HBV) infection with compensated liver disease.\u003c\/p\u003e\r\n\u003cstrong\u003eDose and administration method\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e1. Method of administration\u003c\/strong\u003e\r\n- Test: Before starting to take Trafen, test the patient for HIV infection. People with HIV infection should not\r\nUse Trafen alone. In addition, before and during treatment, it is recommended to perform the following according to clinical needs\r\nDetection: serum creatinine, serum phosphorus, creatinine clearance, urine glucose and urine protein.\r\n\r\n- Recommended dose: 25mg (one tablet), taken with food, once a day.\r\n- Renal impairment: It is not recommended for patients whose estimated creatinine clearance rate is less than 15 ml per minute.\r\n- Hepatic impairment: It is not recommended for patients with decompensated (Child-Pugh B or C) hepatic impairment.\r\n\u003cstrong\u003e2. Dosage specifications\u003c\/strong\u003e\r\n- Tablets, 25 mg of tenofovir alafenamide (trafene).\r\n\u003cstrong\u003e3. Contraindications: None.\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eWarnings and Precautions\u003c\/strong\u003e\r\n\r\n- Co-infection of HBV and HIV-1: It is not recommended to use Trafene alone as a treatment for HIV-1 infection, because It may lead to HIV-1 drug resistance.\r\n- New or worsening renal impairment: Before starting to take Trafen The bed assesses serum creatinine and serum phosphorus levels, estimates creatinine clearance, urine glucose and urine protein.\r\n\r\n\u003cstrong\u003eAdverse reactions\u003c\/strong\u003e\r\n\r\nThe most common adverse reactions (incidence rate ≥5%, all grades) include: headache, abdominal pain, fatigue, cough, nausea, and back pain.\r\n\r\n\u003cstrong\u003estorage method\u003c\/strong\u003e\r\n\r\nStore below 30°C (86°F).","brand":"Tongmeng (Lao) Pharmaceutical \u0026 Food Co., Ltd.（TLPH）","offers":[{"title":"Default Title","offer_id":44797946495019,"sku":"RL142023090121","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/1655786768-124c3dee0fbe16a.png?v=1787022077","url":"https:\/\/xomeds.com\/products\/telarfetenofovir-alafenamide","provider":"XOMEDS","version":"1.0","type":"link"}